IGC/SMIS produce low-cost MRI scanner

Article

A joint venture between Intermagnetics General and Surrey MedicalImaging Systems will display a new 0.15-tesla permanent-magnetMRI scanner designed to carry one of the lowest price tags inthe industry. The work-in-progress scanner, IMiG-MRI, will

A joint venture between Intermagnetics General and Surrey MedicalImaging Systems will display a new 0.15-tesla permanent-magnetMRI scanner designed to carry one of the lowest price tags inthe industry. The work-in-progress scanner, IMiG-MRI, will bedisplayed in the booth of SMIS, a company based in Surrey, U.K.(SCAN 7/3/96).

IMiG-MRI features a compact permanent magnet with a 70 x 57-cmelliptical bore designed by ICG, a Latham, NY, company that buildssuperconducting magnets for MRI vendors such as Philips and Hitachi.The magnet's electronics were developed by SMIS, which suppliesspectrometers to Advanced NMR and Magna-Lab.

The scanner's gradient coils are rated at 14 mtesla/m, whilethe entire platform weighs 8 tons and occupies a 35-square-metersuite. The companies plan to emphasize international sales ofIMiG-MRI through a network of distributors.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.